Family Nurse Practitioner Questions,
Answers & Detailed Rationales | Exam Prep
Study Guide
ANCC FNP Exam Version 2 2026/2027 | Family Nurse Practitioner Questions,
Answers & Detailed Rationales | Exam Prep Study Guide
DOCUMENT OVERVIEW
• Comprehensive question practice exam designed to simulate the actual ANCC
Family Nurse Practitioner certification examination with in-depth clinical scenarios
and evidence-based content covering all major practice domains
• Strategic study tool featuring detailed rationales for every question to reinforce
critical thinking, enhance clinical decision-making, and build confidence across
primary care, acute care, chronic disease management, and health promotion
topics
QUESTIONS
QUESTION 1
A 45-year-old male with a history of hypertension and type 2 diabetes
presents with chest pain radiating to his left arm for the past 2 hours. His
blood pressure is 160/95 mmHg, heart rate 102 beats/min, and respiratory
rate 20 breaths/min. His troponin level is 0.05 ng/mL (normal < 0.04 ng/mL).
Which of the following is the most appropriate initial intervention?
A) Administer aspirin 325 mg PO and refer to the emergency department
immediately
B) Start the patient on atorvastatin 80 mg and schedule a stress test for next week
C) Administer oxygen therapy and perform an EKG in the office
,D) Prescribe nitroglycerin sublingual and observe for 30 minutes
E) Initiate beta-blocker therapy and have the patient return for follow-up in 3 days
CORRECT ANSWER: A) Administer aspirin 325 mg PO and refer to the
emergency department immediately
RATIONALE: This patient presents with acute coronary syndrome (ACS) symptoms,
evidenced by chest pain radiating to the arm, elevated troponin level (0.05 ng/mL is
above the normal threshold of 0.04 ng/mL), and multiple cardiovascular risk factors
(hypertension, diabetes, age). The elevated troponin indicates myocardial necrosis.
According to ACC/AHA guidelines, immediate aspirin administration (325 mg) and
emergency department referral are standard first-line interventions for suspected
ACS. This ensures the patient receives appropriate diagnostic testing (serial
troponins, 12-lead EKG, echocardiography) and potential interventions such as
cardiac catheterization or thrombolytic therapy. Options B, D, and E delay
necessary emergency care, and option C is insufficient for ACS management in a
primary care setting.
QUESTION 2
A 38-year-old female with no significant past medical history presents with
fatigue, dyspnea on exertion, and palpitations for 3 weeks. Physical
examination reveals a systolic murmur best heard at the left lower sternal
border. Her hemoglobin is 8.2 g/dL (normal 12-16 g/dL) and MCV is 72 fL
(normal 80-100 fL). Which of the following is the most likely diagnosis?
A) Acute leukemia with cardiac involvement
B) Iron deficiency anemia with possible rheumatic heart disease
C) Hyperthyroidism with secondary cardiac complications
D) Pulmonary embolism with anemia
E) Viral myocarditis with septic emboli
CORRECT ANSWER: B) Iron deficiency anemia with possible rheumatic
heart disease
,RATIONALE: The patient presents with classic signs of iron deficiency anemia
(microcytic anemia with MCV 72 fL, hemoglobin 8.2 g/dL) manifesting with fatigue,
dyspnea, and palpitations due to increased cardiac output compensation. The
systolic murmur at the left lower sternal border (aortic area) suggests possible
underlying valvular disease, potentially rheumatic in origin. The combination of
anemia and cardiac murmur warrants evaluation for chronic blood loss (GI source
most common) and valvular pathology. An echocardiogram and iron studies would
be appropriate next steps. Options A, C, D, and E do not explain the microcytic
anemia pattern or are less consistent with the clinical presentation.
QUESTION 3
A 52-year-old male with hypertension and hyperlipidemia is started on
lisinopril 10 mg daily. After 2 weeks, he reports a persistent dry cough. His
potassium level is 5.2 mEq/L (normal 3.5-5.0 mEq/L) and creatinine is 1.1
mg/dL (baseline 0.9 mg/dL). What is the most appropriate next step?
A) Increase the lisinopril dose and add a cough suppressant
B) Continue lisinopril and monitor renal function in 2 weeks
C) Switch to an angiotensin II receptor blocker (ARB) such as losartan
D) Discontinue lisinopril and add amlodipine as monotherapy
E) Add furosemide to manage the hyperkalemia
CORRECT ANSWER: C) Switch to an angiotensin II receptor blocker (ARB)
such as losartan
RATIONALE: The patient is experiencing a well-documented adverse effect of ACE
inhibitors: a dry, persistent cough occurring in 5-10% of patients. This cough is
caused by ACE inhibitor-induced increased levels of bradykinin in the lungs. The
slight elevation in potassium (5.2) and creatinine rise (0.9 to 1.1) are common but
minor changes with ACE inhibitor initiation and warrant monitoring but are not
immediately concerning. ARBs block angiotensin II directly and do not cause the
same bradykinin accumulation, making them an appropriate alternative that
maintains the cardiovascular benefits of the RAAS-blocking class. ARBs rarely cause
, cough. Options A and B ignore a treatable adverse effect; option D loses the RAAS
inhibition; option E is inappropriate for this mild hyperkalemia.
QUESTION 4
A 28-year-old female with no medical history presents with a 10-day history of
fever, malaise, and abdominal pain. Laboratory findings show WBC 12,000/μL
with left shift, and urinalysis reveals 100 WBC/high-power field with positive
nitrites and leukocyte esterase. Which of the following is the most
appropriate antibiotic choice for uncomplicated pyelonephritis?
A) Trimethoprim-sulfamethoxazole (TMP-SMX) double-strength twice daily for 3
days
B) Fluoroquinolone (ciprofloxacin 500 mg twice daily for 7 days) or cephalosporin
(cephalexin 500 mg four times daily for 10-14 days)
C) Amoxicillin 500 mg three times daily for 3 days
D) Nitrofurantoin 100 mg twice daily for 5 days
E) Metronidazole 500 mg three times daily for 7 days
CORRECT ANSWER: B) Fluoroquinolone (ciprofloxacin 500 mg twice daily for
7 days) or cephalosporin (cephalexin 500 mg four times daily for 10-14 days)
RATIONALE: This patient presents with acute pyelonephritis, evidenced by fever,
systemic symptoms, flank pain, and urinalysis findings consistent with upper
urinary tract infection. According to IDSA guidelines, uncomplicated pyelonephritis
in non-pregnant women should be treated with oral fluoroquinolones (7-day
course) or oral cephalosporins (10-14 days) as first-line agents. These provide
excellent renal tissue penetration and coverage of common gram-negative
organisms (E. coli, Proteus, Klebsiella). Option A (TMP-SMX) is outdated due to
increased resistance rates. Option C (amoxicillin) is inadequate for pyelonephritis.
Option D (nitrofurantoin) does not achieve adequate concentrations in renal tissue.
Option E (metronidazole) targets anaerobes and is not appropriate here.